KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Profit After Tax: 2018-2025

Historic Profit After Tax for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -$27.2 million.

  • Twist Bioscience's Profit After Tax rose 21.54% to -$27.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.7 million, marking a year-over-year increase of 62.78%. This contributed to the annual value of -$77.7 million for FY2025, which is 62.77% up from last year.
  • According to the latest figures from Q3 2025, Twist Bioscience's Profit After Tax is -$27.2 million, which was down 233.18% from $20.4 million recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's Profit After Tax ranged from a high of $20.4 million in Q2 2025 and a low of -$85.6 million during Q2 2024.
  • For the 3-year period, Twist Bioscience's Profit After Tax averaged around -$40.8 million, with its median value being -$43.0 million (2023).
  • As far as peak fluctuations go, Twist Bioscience's Profit After Tax crashed by 69.59% in 2021, and later surged by 123.83% in 2025.
  • Quarterly analysis of 5 years shows Twist Bioscience's Profit After Tax stood at -$45.6 million in 2021, then increased by 8.21% to -$41.8 million in 2022, then dropped by 2.83% to -$43.0 million in 2023, then grew by 26.53% to -$31.6 million in 2024, then rose by 21.54% to -$27.2 million in 2025.
  • Its Profit After Tax was -$27.2 million in Q3 2025, compared to $20.4 million in Q2 2025 and -$39.3 million in Q1 2025.